HealthEquity, Inc. (NASDAQ:HQY – Get Free Report) CEO Jon Kessler sold 32,326 shares of the business’s stock in a transaction that occurred on Monday, June 24th. The shares were sold at an average price of $82.83, for a total transaction of $2,677,562.58. Following the transaction, the chief executive officer now directly owns 232,176 shares of the company’s stock, valued at approximately $19,231,138.08. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link.
HealthEquity Stock Performance
NASDAQ:HQY opened at $84.30 on Friday. The company has a debt-to-equity ratio of 0.44, a quick ratio of 4.39 and a current ratio of 4.39. HealthEquity, Inc. has a fifty-two week low of $60.20 and a fifty-two week high of $87.72. The business has a 50 day moving average price of $80.92 and a 200-day moving average price of $77.93. The firm has a market cap of $7.33 billion, a PE ratio of 91.63, a price-to-earnings-growth ratio of 1.40 and a beta of 0.55.
HealthEquity (NASDAQ:HQY – Get Free Report) last announced its quarterly earnings results on Monday, June 3rd. The company reported $0.55 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.47 by $0.08. HealthEquity had a net margin of 7.71% and a return on equity of 7.77%. The business had revenue of $287.60 million for the quarter, compared to analyst estimates of $278.78 million. Equities research analysts predict that HealthEquity, Inc. will post 2.12 earnings per share for the current year.
Institutional Inflows and Outflows
Analysts Set New Price Targets
Several brokerages have issued reports on HQY. Wells Fargo & Company lifted their target price on shares of HealthEquity from $107.00 to $110.00 and gave the company an “overweight” rating in a research report on Thursday, June 20th. KeyCorp upped their target price on shares of HealthEquity from $95.00 to $100.00 and gave the stock an “overweight” rating in a research report on Wednesday, June 5th. Barrington Research lifted their price target on HealthEquity from $100.00 to $105.00 and gave the stock an “outperform” rating in a research note on Tuesday, June 4th. BTIG Research increased their price objective on HealthEquity from $100.00 to $110.00 and gave the company a “buy” rating in a research report on Wednesday, March 20th. Finally, JMP Securities boosted their target price on HealthEquity from $101.00 to $105.00 and gave the stock a “market outperform” rating in a research report on Tuesday, June 4th. One research analyst has rated the stock with a hold rating and twelve have issued a buy rating to the stock. According to MarketBeat, HealthEquity currently has a consensus rating of “Moderate Buy” and an average target price of $101.67.
Read Our Latest Stock Report on HQY
About HealthEquity
HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.
Featured Articles
- Five stocks we like better than HealthEquity
- Ride Out The Recession With These Dividend KingsĀ
- BlackBerry Stock: Strong Earnings, Profitability Challenges Ahead
- Why is the Ex-Dividend Date Significant to Investors?
- Progress Software Stock Back in the Green After Beating Forecasts
- Best Stocks Under $10.00
- Goldman Sachs Raises Stock Target for Affirm: Key Insights
Receive News & Ratings for HealthEquity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HealthEquity and related companies with MarketBeat.com's FREE daily email newsletter.